Naphazoline Hydrochloride/Neostigmine methylsulfate

盐酸萘甲唑啉/甲硫酸新斯的明

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNaphazoline Hydrochloride/Neostigmine methylsulfate
Drug Alias Name复方萘维新滴眼液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor agonistsAcetylcholinesterase inhibitorsMuscle relaxation antagonists
TargetsAlpha adrenergic receptorAcetylcholinesterase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Naphazoline HydrochlorideNeostigmine methylsulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A